IL107870A - Pharmaceutical compositions having an antidepressant activity comprising pramipexol - Google Patents

Pharmaceutical compositions having an antidepressant activity comprising pramipexol

Info

Publication number
IL107870A
IL107870A IL10787093A IL10787093A IL107870A IL 107870 A IL107870 A IL 107870A IL 10787093 A IL10787093 A IL 10787093A IL 10787093 A IL10787093 A IL 10787093A IL 107870 A IL107870 A IL 107870A
Authority
IL
Israel
Prior art keywords
amino
propyl
pramipexol
acid addition
pharmacologically acceptable
Prior art date
Application number
IL10787093A
Other languages
English (en)
Other versions
IL107870A0 (en
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of IL107870A0 publication Critical patent/IL107870A0/xx
Publication of IL107870A publication Critical patent/IL107870A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL10787093A 1992-12-05 1993-12-03 Pharmaceutical compositions having an antidepressant activity comprising pramipexol IL107870A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4241013A DE4241013A1 (de) 1992-12-05 1992-12-05 Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung

Publications (2)

Publication Number Publication Date
IL107870A0 IL107870A0 (en) 1994-04-12
IL107870A true IL107870A (en) 1996-12-05

Family

ID=6474503

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10787093A IL107870A (en) 1992-12-05 1993-12-03 Pharmaceutical compositions having an antidepressant activity comprising pramipexol

Country Status (28)

Country Link
US (1) US6191153B1 (cs)
EP (1) EP0675717B1 (cs)
JP (1) JP3221880B2 (cs)
KR (1) KR100311165B1 (cs)
CN (1) CN1052400C (cs)
AT (1) ATE183091T1 (cs)
AU (1) AU674378B2 (cs)
BG (1) BG62475B1 (cs)
CA (1) CA2150131C (cs)
CZ (1) CZ282679B6 (cs)
DE (2) DE4241013A1 (cs)
DK (1) DK0675717T3 (cs)
ES (1) ES2136725T3 (cs)
FI (1) FI952734A0 (cs)
GR (1) GR3031521T3 (cs)
HU (1) HU221014B1 (cs)
IL (1) IL107870A (cs)
MX (1) MX9307644A (cs)
NO (1) NO306930B1 (cs)
NZ (1) NZ258876A (cs)
PL (1) PL309282A1 (cs)
RU (1) RU2157685C2 (cs)
SG (1) SG49228A1 (cs)
SK (1) SK281441B6 (cs)
TW (1) TW362973B (cs)
UA (1) UA35604C2 (cs)
WO (1) WO1994013287A1 (cs)
ZA (1) ZA939065B (cs)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650420A (en) * 1994-12-15 1997-07-22 Pharmacia & Upjohn Company Pramipexole as a neuroprotective agent
US6156777A (en) 1994-12-15 2000-12-05 Pharmacia & Upjohn Company Use of pramipexole as a neuroprotective agent
US6001861A (en) * 1998-01-16 1999-12-14 Pharmacia & Upjohn Company Use of pramipexole in the treatment of restless legs syndrome
DE19830201A1 (de) * 1998-07-07 2000-01-13 Boehringer Ingelheim Pharma Mittel mit antidepressiver Wirkung
CA2301899C (en) * 1998-07-27 2008-11-18 Boehringer Ingelheim Pharma Kg Agent with an antidepressant activity
PE20011074A1 (es) 2000-02-23 2001-10-04 Upjohn Co Uso de pramipexol en el tratamiento de trastornos de adiccion
CA2415815A1 (en) * 2000-07-06 2002-01-17 Nigel H. Greig Tetrahydrobenzothiazole analogues as neuroprotective agents
WO2002069974A1 (en) * 2001-03-05 2002-09-12 Andrew Holman Administration of sleep restorative agents
EP1260221A3 (en) * 2001-05-23 2002-12-18 Pfizer Products Inc. Combination treatment for depression and anxiety
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
US6727247B2 (en) * 2001-12-10 2004-04-27 Hoffman-La Roche Inc. Substituted benzothiazole amide derivatives
US8679533B2 (en) * 2002-07-25 2014-03-25 Pharmacia Corporation Pramipexole once-daily dosage form
GB2394951A (en) * 2002-11-04 2004-05-12 Cipla Ltd One pot synthesis of 2,6-diamino-4,5,6,7-tetrahydro-benzothiazole
DE102004006808A1 (de) 2004-02-11 2005-09-01 Grünenthal GmbH Substituierte 4,5,6,7-Tetrahydro-benzothiazol-2-ylamin-Verbindungen
DK1781260T4 (da) * 2004-08-13 2014-06-23 Boehringer Ingelheim Int Tabletformulering med forlænget frigivelse indeholdende pramipexol eller et farmaceutisk acceptabelt salt deraf, fremgangsmåde til fremstilling deraf og anvendelse deraf
EA200700388A1 (ru) * 2004-08-13 2007-08-31 Бёрингер Ингельхайм Интернациональ Гмбх Композиция пеллеты пролонгированного высвобождения, содержащая прамипексол или его фармацевтически приемлемую соль, способ её изготовления и её применение
BRPI0607684A2 (pt) * 2005-04-04 2009-09-22 Takeda Pharmaceutical composição farmacêutica, método para prevenir ou tratar distúrbios de depressão ou ansiedade, e, uso de (s)-n-[2-(1,6,7,8-tetraidro-2h-indeno[5,4-b]furan-8-il)-eti l]-propionamida
WO2007045620A1 (de) * 2005-10-18 2007-04-26 Boehringer Ingelheim International Gmbh Verwendung von pramipexol zur behandlung des moderaten bis schweren restless legs syndroms (rls)
CA2641665A1 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Modified release formulation
WO2007090883A1 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Extended release formulation
IL312486B2 (en) * 2017-04-10 2025-05-01 Chase Therapeutics Corp NK1 antagonist combination and method for treating synucleinopathies
HUE070223T2 (hu) 2017-06-30 2025-05-28 Chase Therapeutics Corp NK-1-antagonista készítmények és eljárások depresszió kezelésében történõ alkalmazásra
TWI672472B (zh) * 2018-08-15 2019-09-21 鄭映芳 飲料製冰機裝置
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3572485D1 (en) * 1984-12-22 1989-09-28 Thomae Gmbh Dr K Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
DE3930282A1 (de) * 1989-09-11 1991-03-21 Boehringer Ingelheim Kg Verwendung von dopamin-autorezeptor-agonisten bei der behandlung von drogenabhaengigkeit

Also Published As

Publication number Publication date
PL309282A1 (en) 1995-10-02
HU9501623D0 (en) 1995-08-28
EP0675717A1 (de) 1995-10-11
FI952734A7 (fi) 1995-06-05
SK74095A3 (en) 1996-05-08
KR100311165B1 (ko) 2001-12-28
NO952207L (no) 1995-06-02
WO1994013287A1 (de) 1994-06-23
BG62475B1 (bg) 1999-12-30
CA2150131A1 (en) 1994-06-23
TW362973B (en) 1999-07-01
SK281441B6 (sk) 2001-03-12
JP3221880B2 (ja) 2001-10-22
CN1052400C (zh) 2000-05-17
NO952207D0 (no) 1995-06-02
KR950703953A (ko) 1995-11-17
MX9307644A (es) 1994-06-30
ATE183091T1 (de) 1999-08-15
FI952734L (fi) 1995-06-05
JPH08504201A (ja) 1996-05-07
ZA939065B (en) 1994-08-04
HUT71798A (en) 1996-02-28
NZ258876A (en) 1997-07-27
AU674378B2 (en) 1996-12-19
NO306930B1 (no) 2000-01-17
UA35604C2 (uk) 2001-04-16
AU5715294A (en) 1994-07-04
DE4241013A1 (de) 1994-06-09
DK0675717T3 (da) 2000-02-28
FI952734A0 (fi) 1995-06-05
US6191153B1 (en) 2001-02-20
HU221014B1 (hu) 2002-07-29
DE59309733D1 (de) 1999-09-16
SG49228A1 (en) 1998-05-18
HK1019003A1 (en) 2000-01-14
RU2157685C2 (ru) 2000-10-20
ES2136725T3 (es) 1999-12-01
IL107870A0 (en) 1994-04-12
CZ282679B6 (cs) 1997-08-13
EP0675717B1 (de) 1999-08-11
BG99700A (bg) 1996-04-30
CN1091635A (zh) 1994-09-07
CA2150131C (en) 2004-09-21
CZ144095A3 (en) 1996-03-13
GR3031521T3 (en) 2000-01-31

Similar Documents

Publication Publication Date Title
CA2150131C (en) Use of 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazole as a pharmaceutical composition having an antidepressant activity
EP1350511B1 (en) Medicinal compositions containing aspirin
KR20090021169A (ko) Ｒ(+) 및 ｓ(-) 프라미펙솔을 포함하는 조성물 및 이의 사용 방법
EP1181935B1 (en) Use of Olanzapine for the treatment of mental disorders resulting from cerebrovascular disorders
LT3119B (en) Pharmaceutical composition and process for the preparation thereof
EP0500851B1 (en) Process for the preparation of a tablet or dragee composition containing a heat-, light- and moisture-sensitive active ingredient having monoclinic crystal structure
FI96480B (fi) Menetelmä pitkävaikutteisen moniraetabletin valmistamiseksi
EP0319074B1 (en) Pharmaceutical composition and process for its preparation
US4851408A (en) Use of 6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazol[5,4-d]azepine for releasing growth hormone
JP2001500526A (ja) 粘液溶解剤としての２−メチル−チアゾリジン−２，４−ジカルボン酸の使用
EP0216072B1 (en) Use of dibenz[cd,f]indole derivatives in the prevention of alcohol abuse
JPS6056974A (ja) 環式ジチオジアセトアミドおよびその製造方法並びに薬剤
US4152435A (en) Compositions and methods to treat hypertension comprising a pyridazine and N-amidino-2-(2,6-dichlorophenyl) acetamide
AU2001286798B2 (en) Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions
JPH11130672A (ja) 脂質過酸化抑制剤
KR950005869B1 (ko) 위염 치료제
JPH0466529A (ja) 細胞変性抑制並びに臓器毒性軽減剤
JPH02215718A (ja) ４―（１―イミダゾリルメチル）ケイ皮酸を有効成分として含有する薬剤
JPH01168615A (ja) 制吐作用薬剤
IL112062A (en) Pharmaceutical preparations containing derivatives of 2-methylamino-2-phenylcyclohexanone
TOTHENIC et al. Calcium hydrogen phosphate. Source
JPH03200727A (ja) 喘息治療剤
MXPA00012880A (en) Agents with an antidepressive effect
JPH0455405B2 (cs)
EP0946181A1 (en) Use of 2-(2-morpholinophenyl) guanidine derivatives for the treatment of diabetes complications

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired